We are a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which we are able to genetically select patients we believe will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors’ underlying genetics rather than histology. Our corporate offices are located at 8000 Jarvis Avenue, Suite 204, Newark, California.
Market Cap | 99.149 Million | Shares Outstanding | 26.51 Million | Avg 30-day Volume | 411.869 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.39 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -61.962 Million |
Price to Book Value | 1.1752 | Operating Margin | 0.0 | Enterprise Value | 11.333 Million |
Current Ratio | 9.723 | EPS Growth | 0.814 | Quick Ratio | 9.443 |
1 Yr BETA | 1.7772 | 52-week High/Low | 22.22 / 2.15 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -265.3046 | Altman Z-Score | 4.3428 | Free Cash Flow to Firm | -37.251 Million |
Earnings Report | 2022-08-09 |
Please sign in first
25 Thousand total shares from 1 transactions
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
VELLANKI AVANISH CHAIRMAN AND CEO |
|
2,471,627 | 2022-06-01 | 4 |
DOEBELE ROBERT SEE REMARKS |
|
481,827 | 2022-04-13 | 3 |
BRYCE RICHARD PAUL CHIEF MEDICAL OFFICER |
|
53,064 | 2022-01-07 | 1 |
CABATUAN NELSON SEE REMARKS |
|
32,000 | 2022-01-07 | 1 |
BIOTECHNOLOGY VALUE FUND II LP |
|
8,008,205 | 2022-01-06 | 4 |
|
2,487,019 | 2021-10-07 | 1 | |
|
840,326 | 2021-09-21 | 1 | |
|
24,000 | 2021-05-14 | 0 | |
CORMORANT ASSET MANAGEMENT, LP CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP |
|
No longer subject to file | 2021-04-27 | 0 |
|
8,796 | 2021-04-27 | 0 | |
|
4,277,215 | 2021-04-23 | 0 | |
|
4,277,215 | 2021-04-23 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
VELLANKI AVANISH - Director - Officer - > 10% Owner CHAIRMAN AND CEO |
2022-06-02 16:05:41 -0400 | 2022-06-01 | P | 25,000 | $2.29 | a | 2,471,627 | direct | -7.4074 | -7.4074 | 7.037 | 4 | -7.4074 | 2 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
RAIN THERAPEUTICS INC RAIN | 2022-06-24 22:15:03 UTC | -23.8781 | 25.4481 | 20000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 21:45:03 UTC | -23.8781 | 25.4481 | 20000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 21:15:04 UTC | -23.8781 | 25.4481 | 20000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 20:45:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 20:15:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 19:45:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 19:15:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 18:45:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 18:15:04 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 17:45:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 17:15:03 UTC | -23.8781 | 25.4481 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 16:45:03 UTC | -22.1051 | 23.6751 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 16:15:03 UTC | -22.1051 | 23.6751 | 15000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 15:45:03 UTC | -22.1051 | 23.6751 | 9000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 15:15:03 UTC | -22.1051 | 23.6751 | 3000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 14:45:03 UTC | -19.8826 | 21.4526 | 3000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 14:15:03 UTC | -19.8826 | 21.4526 | 2000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 13:45:03 UTC | -19.8826 | 21.4526 | 2000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-24 13:15:03 UTC | -19.8826 | 21.4526 | 3000 |
RAIN THERAPEUTICS INC RAIN | 2022-06-23 15:45:03 UTC | -19.8826 | 21.4526 | 700 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|